Symbol="ATHA"
AssetType="Common Stock"
Name="Athira PharmaÂ Inc"
Description="Athira Pharma, Inc., a late-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and stop neurodegradation. The company is headquartered in Bothell, Washington."
CIK="1620463"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="4000 MASON ROAD, SUITE 300, BOX 352141, SEATTLE, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="116508000"
EBITDA="-99472000"
PERatio="None"
PEGRatio="None"
BookValue="5.56"
DividendPerShare="0"
DividendYield="0"
EPS="-2.8"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.23"
ReturnOnEquityTTM="-0.4"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.8"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="8.4"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.473"
EVToRevenue="-"
EVToEBITDA="1.15"
Beta="2.785"
num_52WeekHigh="4.41"
num_52WeekLow="2.22"
num_50DayMovingAverage="2.951"
num_200DayMovingAverage="3.066"
SharesOutstanding="37950600"
DividendDate="None"
ExDividendDate="None"
symbol="ATHA"
open="2.94"
high="3.15"
low="2.94"
price="3.07"
volume="283865.00"
latest_trading_day="2023-07-14"
previous_close="2.94"
change="0.13"
change_percent="4.4218%"
aroon_positive_momentum_days="42"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="42"
Volume_recent_avg="259887"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.43"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_30"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="42"
Aroon_momentum_negative="58"
image_negative_thumbnail_id_1="161"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0015.jpeg"
image_negative_thumbnail_id_2="148"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0028.jpeg"
image_neutral_thumbnail_id_1="548"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0051.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="676"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_positive_thumbnail_id_2="988"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0150.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1196"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
